Terms ending in 2033
Every in-force patent on Roche Molecular Systems, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,945,882 | DNA Polymerases with Improved Activity In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 9,080,217 | Methods for Detection of Clostridium Difficile In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 9,796,966 | DNA Polymerases with Improved Activity In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 9,476,091 | Use of G-Clamp for Improved Allele-SpecificPCR In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 9,816,145 | Compositions for Detection of Clostridium Difficile In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 9,133,497 | Systems and Methods for Detection of Cells Using Engineered Transduction Particles In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 10,240,212 | Systems and Methods for Detection of Cells Using Engineered Transduction Particles In force · Low confidence | Roche Molecular Systems, Inc. | In force | Low confidence | |
| US 9,090,883 | DNA Polymerases with Improved Activity In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 9,932,633 | Methods for Assessing RNA Quality In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 9,702,017 | HEV Assay In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| 18 more term ends in 2033 · Pro | |||||
10 of 28 patents shown. Soonest term end first, then patent number.
Pro members see all 28.
26 of these are in force and held by Roche Molecular Systems, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.